21
Apr
Lycotec quest to target the deadliest of crystals
Lycotec Ltd, a biotech company based in Cambridge UK, is raising funds to undertake a phase II clinical trial which would target cholesterol crystals. These crystals are one of the main causes of the rupture of atherosclerotic plaques. After breaking the cap of a vulnerable plaque, the crystals protrude into the lumen of coronary or […]
Read more
Categories
Recent posts
-
Lycotec CEO, Dr Ivan Petyaev to attend The Future Food-Tech Summit9th October 2019
-
Lycotec Turns “Bad” Fats to Good17th September 2018
Newsletter
Subscribe to our weekly newsletter now. Enter your email and name and click subscribe
Recent Tweets
-
The average person will spend 100 mins every day watching online videos in 2021. 🤯 So how do you make your videos… https://t.co/dvr630h5Hz
3 days ago -
Understanding the art of @YouTube channel management will help you level up your video marketing game. So we've put… https://t.co/S3mD973FTk
4 days ago -
The right @powerpoint template can make or break a presentation. So if you're preparing a presentation, ensure your… https://t.co/Dk1V4RRNFH
6 days ago
Recent Comments